12:00 AM
Oct 19, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Gardasil: Post-marketing study data

Harvard University researchers published a cost-effectiveness analysis in the British Medical Journal showing that HPV vaccination programs for preadolescent girls would result in <$50,000 per quality-adjusted life year (QALY). Including preadolescent boys in...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >